Alberto Cifuentes

Alberto Cifuentes

Auto-generated profile, based on publicly available information

Alberto Cifuentes

Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
Felisa Reyes-OrtegaFelisa Reyes-Ortega
Felisa Reyes-Ortega
ACAlberto Cifuentes
Alberto Cifuentes
GRGema Rodriguez
Gema Rodriguez
MAMaría Rosa Aguilar De Armas
María Rosa Aguilar De Armas
ÁGÁlvaro González-Gómez
Álvaro González-Gómez
JRJulio San Román
Julio San Román

21 April 2011 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
PDF file
MRMarta Rodríguez
Marta Rodríguez
GPGemma Pascual
Gemma Pascual
SSSandra Sotomayor
Sandra Sotomayor
BPBárbara Pérez-Köhler
Bárbara Pérez-Köhler
ACAlberto Cifuentes
Alberto Cifuentes
JBJuan Manuel Bellón
Juan Manuel Bellón
The intraperitoneal behavior of a prosthetic material used to repair a hernia is key to the success of the postimplant repair process. This study was designed to laparoscopically examine the real-time behavior of three composite meshes incorporating a chemical adhesion barrier when placed in contact with the visceral peritoneum. The defects of 7 × 5 cm were created in the ventral abdominal wall of 18 New Zealand White rabbits and repaired using Parietex Composite® (n = 6), Sepramesh® (n = 6), or Proceed® (n = 6). At 24 hr, 3, 7, and 14 days postimplant, adhesion formation was quantified by subjecting photographs obtained during laparoscopy to image analysis. At 14 days, specimens of the implants and surrounding host tissue were obtained for histologic, morphometric, and immunohistochemical analyses. There were no cases of infection and/or rejection of the implant. Adhesion formation followed by laparoscopy 3, 7, and 14 days after implant was significantly lower for Parietex® than the other biomaterials. Degradation of the chemical barrier occurred earliest in Sepramesh®, this barrier being most stable at 14 days for the Parietex® implants. Macrophage counts were significantly greater for Sepramesh®. The thickness of the neoformed peritoneum formed on the three implants varied significantly (p < .05): 276.89 ± 38.87 μm, 84.49 ± 19.05 μm, and 161.97 ± 47.05 μm, respectively for Paritex®, Sepramesh®, and Proceed®. (a) The most stable barrier against biodegradation was that of Parietex®; (b) the first postimplant week was the most critical period for adhesion formation; and (c) all three biomaterials showed good intraperitoneal behavior.

1 October 2014 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
CPConsuelo Pérez-Rico
Consuelo Pérez-Rico
GPGemma Pascual
Gemma Pascual
SSSandra Sotomayor
Sandra Sotomayor
AAAngel Asúnsolo
Angel Asúnsolo
ACAlberto Cifuentes
Alberto Cifuentes
M. Julia BujánM. Julia Buján
M. Julia Buján
Purpose. We evaluated the expression of several extracellular matrix constituents implicated in the synthesis and reticulation of elastin in human pterygium, according to age and sex of the patients. Methods. Pterygia and normal conjunctiva samples were divided into groups according to age (<50/≥50 years) and sex. Tissue was subjected to immunohistochemical staining with anti-lysyl oxidase (LOX), lyxyl oxidase-like 1 (LOXL-1), fibulin (FBLN)-5 and FBLN4, and fibrillin-1 (FBN1) antibodies. Specific primers for the same constituents were used in a quantitative real-time PCR (qRT-PCR) analysis to determine gene expression. Results. The LOXL-1 (P = 0.0002), FBLN5 (P = 0.0035), and FBN1 (P < 0.0001) mRNAs were significantly higher in pterygium than conjunctiva. No differences were found for LOX and FBLN4 mRNA. The expression of LOXL-1 was not affected by age or sex; however, pterygium from men and patients over 50 years old exhibited significantly higher FBLN5/FBN1 expression than did controls. The LOX gene expression was higher in the pathologic samples from the over 50-year-olds compared to the conjunctiva (P = 0.0396) and in men's versus women's pterygium (P = 0.0173). In general, the levels of LOX, LOXL-1, and FBLN5 decreased with age in healthy samples, while the pathology seemed to have increased expression of the three proteins, and even more so in older patients. The FBLN4 and FBN1 immunostaining was slight in all samples, displaying no differences between groups. Conclusions. Several extracellular matrix constituents, LOXs, FBN1, and FBLN5, implicated in the development of elastin, are overexpressed in the subepithelial connective tissue extracellular matrix of human pterygium, supporting our hypothesis that elastic synthesis and reticulation is dysregulated in this type of pathology.

1 June 2016 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
SSSandra Sotomayor
Sandra Sotomayor
GPGemma Pascual
Gemma Pascual
VBVanessa Blanc‐Guillemaud
Vanessa Blanc‐Guillemaud
CMClaudia Mesa‐Ciller
Claudia Mesa‐Ciller
Natalio GArcia-HonduvillaNatalio GArcia-Honduvilla
Natalio GArcia-Honduvilla
M. Julia BujánM. Julia Buján
M. Julia Buján

1 April 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
Verónica Gómez-GilVerónica Gómez-Gil
Verónica Gómez-Gil
GPGemma Pascual
Gemma Pascual
BPBárbara Pérez-Köhler
Bárbara Pérez-Köhler
ACAlberto Cifuentes
Alberto Cifuentes
M. Julia BujánM. Julia Buján
M. Julia Buján
JBJuan Manuel Bellón
Juan Manuel Bellón

6 July 2010 in Journal of Vascular Research
Verified
Journal Article
Open access
PDF file
MRM. Rodríguez
M. Rodríguez
GPGemma Pascual
Gemma Pascual
ACA. Cifuentes
A. Cifuentes
BPBárbara Pérez-Köhler
Bárbara Pérez-Köhler
JBJuan Manuel Bellón
Juan Manuel Bellón
M. Julia BujánM. Julia Buján
M. Julia Buján
Background: Extracellular matrix deposition is the main factor inducing stenotic lesions in arterial grafts. Lysyl oxidases (LOX) play a key role in stabilizing collagen and elastin. Objective: To examine the repair response to arterial allografts in terms of LOX expression and collagen/elastin deposition using LOX inhibitors. Methods: Lewis/Fisher-344 rats were used as donors/recipients. Donor segments were grafted to the right iliac artery of recipients and retrieved 14/30 (short-term) or 90/180 days (long-term) after surgery. One group of animals was injected with a potent irreversible LOX inhibitor daily for 30 days. Results: Intimal hyperplasia increased in thickness until 90/180 days postsurgery. Elastin showed great expression in the neointima at 14/30 days and in the media at 90/180 days. LOX/LOXL1 were similarly expressed in the arterial wall during the first month. In the long term, their overexpression was confined to neointimal layers. At 14 days, collagen types I/III were identified in the grafts. The neointima acquired collagen I over time. In the group of animal treated with the LOX inhibitor, intimal hyperplasia was significantly inhibited. Conclusion: LOX were overexpressed in late stages of intimal hyperplasia in the allografts. LOX inhibitors prevented the development of the neointimal layer, such that their modulation could reduce the excessive extracellular matrix deposition that leads to stenosis.